CVS Health will begin manufacturing cheaper ‘biosimilar’ drugs
CVS Health is launching a new subsidiary unit, Cordavis, that will collaborate with drug manufacturers...
CVS Health is launching a new subsidiary unit, Cordavis, that will collaborate with drug manufacturers...
Biogen and Sage Therapeutics’ collaboration to develop Zurzuvae has proved fruitful. The FDA approved the...
Pfizer’s COVID-19 antiviral pill will already have some competition in the US. As the Associated...